Cargando…

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

Detalles Bibliográficos
Autores principales:	Oczko-Wojciechowska, Malgorzata, Swierniak, Michal, Krajewska, Jolanta, Kowalska, Malgorzata, Kowal, Monika, Stokowy, Tomasz, Wojtas, Bartosz, Rusinek, Dagmara, Pawlaczek, Agnieszka, Czarniecka, Agnieszka, Szpak-Ulczok, Sylwia, Gawlik, Tomasz, Chmielik, Ewa, Tyszkiewicz, Tomasz, Nikiel, Barbara, Lange, Dariusz, Jarzab, Michal, Wiench, Malgorzata, Jarzab, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353585/ https://www.ncbi.nlm.nih.gov/pubmed/28294124 http://dx.doi.org/10.1038/srep44347

Ejemplares similares

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
por: Rusinek, Dagmara, et al.
Publicado: (2017)

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
por: Wojtas, Bartosz, et al.
Publicado: (2017)

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues
por: Pfeifer, Aleksandra, et al.
Publicado: (2013)

Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2015)

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
por: Szpak-Ulczok, Sylwia, et al.
Publicado: (2020)

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
por: Jarzab, Barbara, et al.
Publicado: (2013)

Novel TG‐FGFR1 and TRIM33‐NTRK1 transcript fusions in papillary thyroid carcinoma
por: Pfeifer, Aleksandra, et al.
Publicado: (2019)

Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of (1)H HR MAS NMR spectroscopy
por: Skorupa, Agnieszka, et al.
Publicado: (2021)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping
por: Fujarewicz, Krzysztof, et al.
Publicado: (2007)

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors
por: Czarniecka, Agnieszka, et al.
Publicado: (2015)

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
por: Rusinek, Dagmara, et al.
Publicado: (2018)

Gene signature of the post-Chernobyl papillary thyroid cancer
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2016)

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma – Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015
por: Czarniecka, Agnieszka, et al.
Publicado: (2021)

A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations
por: Soczomski, Przemysław, et al.
Publicado: (2021)

Analysis options for high-throughput sequencing in miRNA expression profiling
por: Stokowy, Tomasz, et al.
Publicado: (2014)

Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features
por: Zakrzewski, Krzysztof, et al.
Publicado: (2015)

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
por: Krajewska, Jolanta, et al.
Publicado: (2020)

Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal
por: Chechlinska, Magdalena, et al.
Publicado: (2009)

The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report
por: Gawlik, Tomasz, et al.
Publicado: (2010)

Lobo-isthmectomy in the management of differentiated thyroid cancer
por: Krajewska, Jolanta, et al.
Publicado: (2023)

Transcriptomic population markers for human population discrimination
por: Daca-Roszak, P., et al.
Publicado: (2018)

Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision
por: Czarniecka, Agnieszka, et al.
Publicado: (2010)

Comparison of clinical examination with orbital MRI evaluation in patients with thyroid orbitopathy - do we need imaging and when?
por: Król, Aleksandra, et al.
Publicado: (2013)

Endogenous avidin biotin activity (EABA) in thyroid pathology: immunohistochemical study
por: Nikiel, Barbara, et al.
Publicado: (2009)

Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes
por: Kowalewska, Magdalena, et al.
Publicado: (2012)

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
por: Krajewska, Jolanta, et al.
Publicado: (2019)

HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death
por: Wenta, Tomasz, et al.
Publicado: (2019)

Global Gene Expression Profiling in Three Tumor Cell Lines Subjected to Experimental Cycling and Chronic Hypoxia
por: Olbryt, Magdalena, et al.
Publicado: (2014)

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2009)

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
por: Krajewska, Jolanta, et al.
Publicado: (2013)

Differences in Gene-Gene Interactions in Graves’ Disease Patients Stratified by Age of Onset
por: Jurecka-Lubieniecka, Beata, et al.
Publicado: (2016)

Association between Age at Diagnosis of Graves' Disease and Variants in Genes Involved in Immune Response
por: Jurecka-Lubieniecka, Beata, et al.
Publicado: (2013)

Role of nuclear medicine imaging in differential diagnosis of accessory spleens in patients after splenectomy
por: d’Amico, Andrea, et al.
Publicado: (2012)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015
por: Thompson, Ella R., et al.
Publicado: (2017)

Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells
por: Di Maro, Gennaro, et al.
Publicado: (2014)

Gene Expression from Bronchoscopy Obtained Tumour Samples as a Predictor of Outcome in Advanced Inoperable Lung Cancer
por: Suwinski, Rafal, et al.
Publicado: (2012)

Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants
por: Stokowy, Tomasz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tlngqhvrmejinl9bpjg3mfsiuo